#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16444	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2164	750.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1410	1410	C	912	C	885	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16444	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2164	750.0	0	HET	.	.	.	C207T	.	207	207	C	433	433	C	902	C,T	677,190	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30676	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3627	838.5	0	.	n	.	0	T695C	SNP	695	695	T	1061	1061	C	939	C	908	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30676	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3627	838.5	0	.	n	.	0	A1638G	SNP	1638	1638	A	2004	2004	G	975	G,A	943,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30676	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3627	838.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2337	2337	C	934	C	904	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30676	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3627	838.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2411	2411	A	895	A	871	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30676	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3627	838.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2963	2963	C	895	C	868	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	2020	folP	852	852	99.77	folP.l15.c4.ctg.1	1525	131.0	0	.	p	.	0	S68P	NONSYN	202	204	TCG	571	573	CCG	206;205;208	C;C;G	194;199;205	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	2020	folP	852	852	99.77	folP.l15.c4.ctg.1	1525	131.0	0	.	p	.	0	A204V	NONSYN	610	612	GCA	979	981	GTA	189;187;189	G;T,G;A	185;180,1;183	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	2020	folP	852	852	99.77	folP.l15.c4.ctg.1	1525	131.0	1	SNP	p	R228S	1	.	.	682	684	AGC	1051	1053	AGC	182;180;181	A;G;C	177;176;175	folP.WHO_X_01360c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5980	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3412	173.5	1	SNP	p	S91F	1	.	.	271	273	TTC	575	577	TTC	204;205;205	T;T;C	194;196;195	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5980	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3412	173.5	1	SNP	p	D95G	1	.	.	283	285	GGC	587	589	GGC	200;199;197	G;G;C	189;187;183	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5980	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3412	173.5	1	SNP	p	G95N	0	.	.	283	285	GGC	587	589	GGC	200;199;197	G;G;C	189;187;183	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1906	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1323	142.5	1	SNP	p	G45D	0	.	.	133	135	GGC	438	440	GGC	237;235;237	G,A;G;C,T	228,1;226;226,1	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	978	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1013	95.6	0	.	n	.	0	A197.	DEL	197	197	A	658	658	A	229	A	223	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5406	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2950	181.2	1	SNP	p	D86N	0	.	.	256	258	GAC	608	610	GAC	194;195;196	G;A,C;C	187;182,1;187	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5406	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2950	181.2	1	SNP	p	R87I	0	.	.	259	261	CGT	611	613	CGT	197;197;198	C;G;T	189;190;189	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5406	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2950	181.2	1	SNP	p	S87R	1	.	.	259	261	CGT	611	613	CGT	197;197;198	C;G;T	189;190;189	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5406	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2950	181.2	1	SNP	p	R87W	0	.	.	259	261	CGT	611	613	CGT	197;197;198	C;G;T	189;190;189	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5406	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2950	181.2	1	SNP	p	S88P	0	.	.	262	264	TCC	614	616	TCC	200;198;198	T;C;C	192;189;190	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4682	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2543	182.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1461	1463	GGC	236;236;234	G;G;C	226;228;221	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2237	198.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1177	1179	GCC	263;261;261	G,A;C;C	248,1;251;248	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2237	198.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1180	1182	ATG	263;264;261	A;T;G	250;250;246	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2237	198.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1192	1194	ACC	255;254;253	A,C;C;C	237,1;242;242	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2237	198.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1192	1194	ACC	255;254;253	A,C;C;C	237,1;242;242	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2237	198.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1693	1695	ACC	227;226;228	A;C;C	212;217;220	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2237	198.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1747	1749	GCG	220;220;220	G;C;G	216;213;212	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2237	198.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1747	1749	GCG	220;220;220	G;C;G	216;213;212	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2237	198.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1870	1872	GGT	167;167;168	G;G;T	165;164;162	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2237	198.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1879	1881	AGC	165;160;158	A;G;C	157;155;156	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2237	198.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1897	1899	CCG	139;141;140	C,G;C,G;G,C	124,3;127,2;125,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6218	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3211	191.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1688	1690	CCG	200;202;200	C;C;G,T	190;195;189,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2630	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1680	154.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	463	463	C	185	C	175	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3082	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1611	189.4	1	SNP	p	G120K	1	.	.	358	360	AAG	622	624	AAG	248;250;248	A,C;A;G,A	242,1;244;234,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3082	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1611	189.4	1	SNP	p	N121D	0	.	.	361	363	AAC	625	627	AAC	249;250;250	A;A;C,A	240;238;235,4	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3082	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1611	189.4	1	SNP	p	A121N	1	.	.	361	363	AAC	625	627	AAC	249;250;250	A;A;C,A	240;238;235,4	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10516	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4857	214.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1324	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1090	120.7	1	SNP	p	V57M	1	.	.	169	171	ATG	552	554	ATG	275;276;271	A;T;G	268;266;263	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
